ATE147269T1 - Behandlung von männerunfruchtbarkeit - Google Patents

Behandlung von männerunfruchtbarkeit

Info

Publication number
ATE147269T1
ATE147269T1 AT91914234T AT91914234T ATE147269T1 AT E147269 T1 ATE147269 T1 AT E147269T1 AT 91914234 T AT91914234 T AT 91914234T AT 91914234 T AT91914234 T AT 91914234T AT E147269 T1 ATE147269 T1 AT E147269T1
Authority
AT
Austria
Prior art keywords
treatment
mis
testes
descent
disclosed
Prior art date
Application number
AT91914234T
Other languages
English (en)
Inventor
Patricia K Donahoe
John Medwyn Hutson
Original Assignee
Gen Hospital Corp
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp, Univ Melbourne filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE147269T1 publication Critical patent/ATE147269T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/225—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT91914234T 1990-05-16 1991-07-09 Behandlung von männerunfruchtbarkeit ATE147269T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPK109390 1990-05-16

Publications (1)

Publication Number Publication Date
ATE147269T1 true ATE147269T1 (de) 1997-01-15

Family

ID=3774816

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91914234T ATE147269T1 (de) 1990-05-16 1991-07-09 Behandlung von männerunfruchtbarkeit

Country Status (6)

Country Link
EP (1) EP0538394B1 (de)
JP (1) JPH06500080A (de)
AT (1) ATE147269T1 (de)
CA (1) CA2087026A1 (de)
DE (1) DE69124095D1 (de)
WO (1) WO1992000752A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166713B2 (en) 2001-12-11 2007-01-23 Texas Techn University Variant cleavage stimulation factor and its encoding nucleic acid
MA41629A (fr) * 2015-03-04 2018-01-09 Center For Human Reproduction Compositions et méthodes d'utilisation de l'hormone anti-müllérienne pour le traitement de l'infertilité
US11518793B2 (en) 2016-12-14 2022-12-06 The General Hospital Corporation Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotection, and ovarian reserve and uterine preservation
US11696747B2 (en) 2017-09-29 2023-07-11 Nanovare Sas Devices and methods for semen analysis
AU2022245213A1 (en) * 2021-03-22 2023-10-05 The General Hospital Corporation Compositions and methods for preventing or delaying puberty in prepubescent non-human animals and humans

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404188A (en) * 1981-07-29 1983-09-13 Massachusetts General Hospital Purified Mullerian Inhibiting Substance and method of purification
US4549986A (en) * 1983-12-23 1985-10-29 The Salk Institute For Biological Studies Human CGRP
US4753794A (en) * 1986-06-24 1988-06-28 The General Hospital Corporation Use of mullerian inhibiting substance as a contraceptive agent

Also Published As

Publication number Publication date
JPH06500080A (ja) 1994-01-06
EP0538394A1 (de) 1993-04-28
EP0538394B1 (de) 1997-01-08
DE69124095D1 (de) 1997-02-20
WO1992000752A1 (en) 1992-01-23
CA2087026A1 (en) 1992-01-11

Similar Documents

Publication Publication Date Title
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
DK0731699T3 (da) Fremgangsmåde til reduktion af legemsfedt i dyr ved indgivelse af konjugeret linolsyre
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
EP0751781A4 (de) Methode zur prävention oder behandlung einer krankheit, dadurch charakterisiert, dass die neoplastischen zellen cd40 exprimieren
EP0526544A4 (en) Therapeutic uses of actin-binding compounds
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
DE69014137D1 (de) Immunogenische Zusammensetzungen gegen Gastrin-Peptide.
MX9401294A (es) Derivados de azolona sustituida
SE9603725D0 (sv) New teatment
NO894222D0 (no) Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder.
ATE453402T1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
DE69625682D1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
ATE147269T1 (de) Behandlung von männerunfruchtbarkeit
DK0579488T3 (da) Præparat til behandling af mastitis og matritis
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
DK325289D0 (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
ATE297739T1 (de) Endothelin-antagonisten zur behandlung von herzversagen
DE69030584D1 (de) Verfahren sowie zusammensetzungen zur behandlung mit vitaminmineral
ATE435023T1 (de) Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen
RU95112948A (ru) Способ лечения инфекционно-воспалительных заболеваний органов репродуктивной системы у мужчин
DE3373978D1 (en) Composition for the care or treatment of the human skin
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
FR2676622B1 (fr) Prothese capillaire et procede de traitement des calvities au moyen de cette prothese.
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties